| Andexanet alfa for the reversal of factor Xa inhibitor activity DM Siegal, JT Curnutte, SJ Connolly, G Lu, PB Conley, BL Wiens, ... New England Journal of Medicine 373 (25), 2413-2424, 2015 | 1215 | 2015 |
| High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database JT Heywood, GC Fonarow, MR Costanzo, VS Mathur, JR Wigneswaran, ... Journal of cardiac failure 13 (6), 422-430, 2007 | 962 | 2007 |
| Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens S Patel, HB Goodson IV, JM Elkins, CA Ball, VS Mathur US Patent 7,766,961, 2010 | 736 | 2010 |
| A longitudinal study of uremic pruritus in hemodialysis patients VS Mathur, J Lindberg, M Germain, G Block, J Tumlin, M Smith, M Grewal, ... Clinical Journal of the American Society of Nephrology 5 (8), 1410-1419, 2010 | 434 | 2010 |
| Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy JA Tumlin, A Wang, PT Murray, VS Mathur American heart journal 143 (5), 894-903, 2002 | 279 | 2002 |
| The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects VS Mathur, SK Swan, LJ Lambrecht, S Anjum, J Fellmann, D McGuire, ... Critical care medicine 27 (9), 1832-1837, 1999 | 207 | 1999 |
| Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature VS Mathur, JL Olson, TM Darragh, TSB Yen American journal of kidney diseases 29 (5), 854-858, 1997 | 175 | 1997 |
| Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges S Shirazian, O Aina, Y Park, N Chowdhury, K Leger, L Hou, N Miyawaki, ... International Journal of Nephrology and Renovascular Disease 10, 11-26, 2017 | 148 | 2017 |
| Use of fenoldopam to prevent radiocontrast nephropathy in high‐risk patients H Madyoon, L Croushore, D Weaver, V Mathur Catheterization and cardiovascular interventions 53 (3), 341-345, 2001 | 130 | 2001 |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An … M Crowther, V Mathur, M Kitt, G Lu, P Conley, S Hollenbach, J Castillo, ... Blood 122, 3636, 2013 | 128 | 2013 |
| Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled … GS Thomas, BR Tammelin, GL Schiffman, R Marquez, DL Rice, D Milikien, ... Journal of Nuclear Cardiology 15, 319-328, 2008 | 124 | 2008 |
| Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure P McCullough, J Kuncheria, V Mathur Reviews in Cardiovascular Medicine 4 (suppl 7), S3-S12, 2003 | 110* | 2003 |
| The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure J Butler, C Emerman, WF Peacock, VS Mathur, JB Young Nephrology Dialysis Transplantation 19 (2), 391-399, 2004 | 108 | 2004 |
| Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial JA Tumlin, LM Dunbar, S Oparil, V Buckalew, CV Ram, V Mathur, D Ellis, ... Academic Emergency Medicine 7 (6), 653-662, 2000 | 104 | 2000 |
| Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double … BR Leaker, B O’Connor, TT Hansel, PJ Barnes, L Meng, VS Mathur, ... Journal of Nuclear Cardiology 15, 329-336, 2008 | 98 | 2008 |
| The RegEx trial: a randomized, double-blind, placebo-and active-controlled pilot study combining regadenoson, a selective A2A adenosine agonist, with low-level exercise, in … GS Thomas, RC Thompson, MI Miyamoto, TK Ip, DL Rice, D Milikien, ... Journal of nuclear cardiology 16 (1), 63-72, 2009 | 96 | 2009 |
| B-type natriuretic peptide: from bench to bedside KF Adams Jr, VS Mathur, M Gheorghiade American heart journal 145 (2), S34-S46, 2003 | 94 | 2003 |
| Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status MB Mathur, VS Mathur, DB Reichling Journal of Pediatric Health Care 24 (1), 14-24, 2010 | 93 | 2010 |
| A phase 2 randomized, double-blind, placebo-controlled trial of PRT064445, a novel, universal antidote for direct and indirect factor Xa inhibitors M Crowther, M Kitt, T Lorenz, V Mathur, G Lu, A Hutchaleelaha, ... J Thromb Haemost 11 (suppl 2), 30, 2013 | 92 | 2013 |
| Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension DE Wesson, V Mathur, N Tangri, Y Stasiv, D Parsell, E Li, G Klaerner, ... The Lancet 394 (10196), 396-406, 2019 | 89 | 2019 |
Mark CrowtherMcMaster UniversityVerified email at mcmaster.ca
